Report: Strong growth for Argentina's pharma industry

04/29/2013 | PharmaTimes (U.K.)

With strong domestic manufacturers, high-quality production standards and an attractive clinical-trial environment, Argentina's pharmaceutical industry should grow rapidly from $5.6 billion in 2012 to an estimated $15 billion by 2020, according to the research firm GlobalData. Domestic manufacturers such as Roemmers and Bago account for half of the nation's drug market, although multinationals such as Abbott, Bayer, GlaxoSmithKline, Novartis and Roche are active as well. Argentina faces challenges from large-scale production facilities in India and China, GlobalData said, and has not yet proven able to innovate and develop New Chemical Entities.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN